488 related articles for article (PubMed ID: 18945219)
1. MTHFR C677T polymorphism and risk of HCC in patients with liver cirrhosis: role of male gender and alcohol consumption.
Fabris C; Toniutto P; Falleti E; Fontanini E; Cussigh A; Bitetto D; Fornasiere E; Fumolo E; Avellini C; Minisini R; Pirisi M
Alcohol Clin Exp Res; 2009 Jan; 33(1):102-7. PubMed ID: 18945219
[TBL] [Abstract][Full Text] [Related]
2. The MTHFR 677C > T polymorphism is associated with an increased risk of hepatocellular carcinoma in patients with alcoholic cirrhosis.
Saffroy R; Pham P; Chiappini F; Gross-Goupil M; Castera L; Azoulay D; Barrier A; Samuel D; Debuire B; Lemoine A
Carcinogenesis; 2004 Aug; 25(8):1443-8. PubMed ID: 15033905
[TBL] [Abstract][Full Text] [Related]
3. Gene--nutrition interactions in coronary artery disease: correlation between the MTHFR C677T polymorphism and folate and homocysteine status in a Korean population.
Huh HJ; Chi HS; Shim EH; Jang S; Park CJ
Thromb Res; 2006; 117(5):501-6. PubMed ID: 15935452
[TBL] [Abstract][Full Text] [Related]
4. [A study on the association of MTHFR C677T polymorphism with genetic susceptibility to hepatocellular carcinoma].
Zhu ZZ; Cong WM; Liu SF; Xian ZH; Wu WQ
Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):196-8. PubMed ID: 16556414
[TBL] [Abstract][Full Text] [Related]
5. Methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) gene polymorphisms as risk factors for hepatocellular carcinoma in a Korean population.
Kwak SY; Kim UK; Cho HJ; Lee HK; Kim HJ; Kim NK; Hwang SG
Anticancer Res; 2008; 28(5A):2807-11. PubMed ID: 19035314
[TBL] [Abstract][Full Text] [Related]
6. Methylenetetrahydrofolate reductase C677T-polymorphism and its association with alcohol withdrawal seizure.
Lutz UC; Batra A; Kolb W; Machicao F; Maurer S; Köhnke MD
Alcohol Clin Exp Res; 2006 Dec; 30(12):1966-71. PubMed ID: 17117960
[TBL] [Abstract][Full Text] [Related]
7. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.
Falleti E; Fabris C; Cmet S; Cussigh A; Bitetto D; Fontanini E; Fornasiere E; Bignulin S; Fumolo E; Bignulin E; Pirisi M; Toniutto P
Liver Int; 2011 Sep; 31(8):1137-43. PubMed ID: 21745286
[TBL] [Abstract][Full Text] [Related]
8. Methylenetetrahydrofolate reductase C677T polymorphism in adult patients with lymphoproliferative disorders and its effect on chemotherapy.
Timuragaoglu A; Dizlek S; Uysalgil N; Tosun O; Yamac K
Ann Hematol; 2006 Dec; 85(12):863-8. PubMed ID: 16944145
[TBL] [Abstract][Full Text] [Related]
9. Methylenetetrahydrofolate reductase C677T polymorphism and liver fibrosis progression in patients with recurrent hepatitis C.
Toniutto P; Fabris C; Falleti E; Cussigh A; Fontanini E; Bitetto D; Fornasiere E; Minisini R; De Feo T; Marangoni F; Pirisi M
Liver Int; 2008 Feb; 28(2):257-63. PubMed ID: 17900242
[TBL] [Abstract][Full Text] [Related]
10. Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients.
Adinolfi LE; Ingrosso D; Cesaro G; Cimmino A; D'Antò M; Capasso R; Zappia V; Ruggiero G
Hepatology; 2005 May; 41(5):995-1003. PubMed ID: 15834927
[TBL] [Abstract][Full Text] [Related]
11. Interaction between the MTHFR C677T polymorphism and alcohol--impact on oral cancer risk and multiple DNA methylation of tumor-related genes.
Supic G; Jovic N; Kozomara R; Zeljic K; Magic Z
J Dent Res; 2011 Jan; 90(1):65-70. PubMed ID: 20940365
[TBL] [Abstract][Full Text] [Related]
12. Protective effect against alcohol dependence of the thermolabile variant of MTHFR.
Saffroy R; Benyamina A; Pham P; Marill C; Karila L; Reffas M; Debuire B; Reynaud M; Lemoine A
Drug Alcohol Depend; 2008 Jul; 96(1-2):30-6. PubMed ID: 18328637
[TBL] [Abstract][Full Text] [Related]
13. Maternal and offspring MTHFR gene C677T polymorphism as predictors of congenital atrial septal defect and patent ductus arteriosus.
Zhu WL; Li Y; Yan L; Dao J; Li S
Mol Hum Reprod; 2006 Jan; 12(1):51-4. PubMed ID: 16373366
[TBL] [Abstract][Full Text] [Related]
14. Interrelationships among genetic C677T polymorphism of 5,10-methylenetetrahydrofolate reductase, biochemical folate status, and lymphocytic p53 oxidative damage in association with tumor malignancy and survivals of patients with hepatocellular carcinoma.
Kuo CS; Huang CY; Kuo HT; Cheng CP; Chen CH; Lu CL; Yang FL; Syu Huang RF
Mol Nutr Food Res; 2014 Feb; 58(2):329-42. PubMed ID: 23996892
[TBL] [Abstract][Full Text] [Related]
15. The MTHFR C677T mutation is not a risk factor recognized for HBV-related HCC in a population with a high prevalence of this genetic marker.
Jiao X; Luo Y; Yang B; Jing L; Li Y; Liu C; Jing X; Wang F; Wang Y; Du Z; Gao Y
Infect Genet Evol; 2017 Apr; 49():66-72. PubMed ID: 28082187
[TBL] [Abstract][Full Text] [Related]
16. Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study.
Nahon P; Sutton A; Rufat P; Faisant C; Simon C; Barget N; Trinchet JC; Beaugrand M; Gattegno L; Charnaux N
Eur J Gastroenterol Hepatol; 2007 May; 19(5):425-31. PubMed ID: 17413295
[TBL] [Abstract][Full Text] [Related]
17. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
[TBL] [Abstract][Full Text] [Related]
18. The MTHFR C677T polymorphism and colorectal cancer: the multiethnic cohort study.
Le Marchand L; Wilkens LR; Kolonel LN; Henderson BE
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1198-203. PubMed ID: 15894672
[TBL] [Abstract][Full Text] [Related]
19. No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancer.
Hekim N; Ergen A; Yaylim I; Yilmaz H; Zeybek U; Oztürk O; Isbir T
Cell Biochem Funct; 2007; 25(1):115-7. PubMed ID: 16134079
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta1 genotypes in cirrhosis: relationship with the occurrence of liver cancer.
Falleti E; Fabris C; Toniutto P; Fontanini E; Cussigh A; Bitetto D; Fornasiere E; Avellini C; Minisini R; Pirisi M
Cytokine; 2008 Nov; 44(2):256-61. PubMed ID: 18809335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
